Alpha 2.0
Login Register
» Authors » Shawn G Kwatra

Shawn G Kwatra

Explore the profile of Shawn G Kwatra including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 269
Citations 1949
Followers 0
Related Specialties
Dermatology
General Medicine
Pharmacology
Top 10 Co-Authors
Yevgeniy R Semenov
Madan M Kwatra
Nishadh Sutaria
Varsha Parthasarathy
Raveena Khanna
Justin Choi
Anusha Kambala
Junwen Deng
Kyle A Williams
Thomas Pritchard
Published In
J Am Acad Dermatol
J Dermatolog Treat
J Invest Dermatol
Medicines (Basel)
JAMA Dermatol
Affiliations
Soon will be listed here.
Recent Articles
1.
Cross-sectional analysis of mental health comorbidities in patients with prurigo nodularis
Frankel D, Ma E, Gage D, Akiska Y, Shahsavari S, Kwatra S
J Am Acad Dermatol . 2025 Mar; PMID: 40089025
No abstract available.
2.
Circulating IgE levels as a biomarker for therapeutic response to dupilumab among patients with prurigo nodularis
DAmiano A, Akiska Y, Kollings J, Bao A, Madan V, Ma E, et al.
Clin Exp Dermatol . 2025 Mar; PMID: 40036329
No abstract available.
3.
Healthcare Resource Utilization and Economic Burden of Prurigo Nodularis in the United States
Kwatra S, Das A, Chang E, Paydar C, Bahloul D, Chen C, et al.
Dermatol Ther (Heidelb) . 2025 Feb; 15(2):413-425. PMID: 39922987
Introduction: The impacts of prurigo nodularis (PN) on healthcare resource utilization (HCRU) and associated costs are unclear. Methods: This retrospective, cross-sectional claims analysis (IQVIA PharMetrics Plus) compared HCRU and costs...
4.
Distinct comorbidity profiles in atopic versus non-atopic prurigo nodularis: a cross-sectional analysis
Bao A, Kollings J, Akiska Y, Gage D, Shahsavari S, Ma E, et al.
Arch Dermatol Res . 2025 Feb; 317(1):356. PMID: 39918619
Prurigo nodularis (PN) is a chronic inflammatory skin condition frequently associated with atopy, yet the relationship between atopic status and comorbidity profiles in PN patients remains poorly understood. Using the...
5.
Patient perspectives on the lived experience of prurigo nodularis: A qualitative approach
DAmiano A, Madan V, Ma E, Cai C, Lulseged B, Ravindra D, et al.
J Am Acad Dermatol . 2025 Jan; PMID: 39870311
No abstract available.
6.
Comprehensive plasma cytokine profiling reveals a distinct endotype of type 2 inflammation in chronic pruritus of unknown origin
Manjunath J, Bao A, Gonzalez W, Vojvoda E, DAmiano A, Patel S, et al.
J Am Acad Dermatol . 2025 Jan; PMID: 39832680
No abstract available.
7.
Targeted dual biologic therapy for erythroderma of unknown etiology guided by high-parameter peripheral blood immunophenotyping
Cornman H, Alphonse M, Dykema A, Kollhoff A, Lee K, Manjunath J, et al.
Sci Rep . 2025 Jan; 15(1):1298. PMID: 39809837
Erythroderma is a severe and heterogeneous inflammatory skin condition with little guidance on the approach to management in cases of unknown etiology. To guide therapeutic selection, we sought to create...
8.
Prevalence of prurigo nodularis in the United States
Kwatra S, Puelles J, Tran O, Brouillette M, Lillehaugen T, Parthasarathy V, et al.
JAAD Int . 2024 Dec; 18:134-136. PMID: 39719959
No abstract available.
9.
Seasonal and geographic variation in cutaneous immune-related adverse events after treatment with immune checkpoint inhibitors
Rajeh A, Roster K, Reynolds K, LeBoeuf N, Sullivan R, Kwatra S, et al.
J Eur Acad Dermatol Venereol . 2024 Dec; PMID: 39707682
No abstract available.
10.
Distinct HLA profile associated with atopic dermatitis in diverse skin types
Ma E, Bao A, Chen M, Akiska Y, Shahsavari S, Gage D, et al.
Arch Dermatol Res . 2024 Dec; 317(1):130. PMID: 39673622
No abstract available.